K. Khan and R. Kerbel highlight the first description of a human antibody against Tie1 with the potential for clinical use in targeting extravasation of tumor cells into organs such as the lung, without having a detrimental effect on immune cell infiltration. Here, TIE1 is linked to neoplasm.